Fluidigm Ships Flex six™ Integrated Fluidic Circuits to Genotyping and Gene Expression Customers SOUTH SAN FRANCISCO, Calif., June 3, 2014 — Fluidigm Corporation (NASDAQ:FLDM) has begun shipping production volumes of its Flex Six™ integrated fluidic circuits (IFCs) to genotyping and gene
Fluidigm to Present at the Bank of America Merrill Lynch 2014 Healthcare Conference SOUTH SAN FRANCISCO, Calif. – May 6, 2014 – Fluidigm Corporation (NASDAQ:FLDM) today announced that Chief Financial Officer Vikram Jog and Vice President of Corporate Development Un Kwon-Casado will present at the
Fluidigm to Announce Q1 2014 Financial Results and Host Conference Call for Investors SOUTH SAN FRANCISCO, Calif., April 23, 2014 — Fluidigm Corporation (NASDAQ:FLDM) will report its first quarter 2014 financial results on May 5, 2014, after close of market.
Fluidigm to Present at the Cowen and Company 34th Annual Health Care Conference SOUTH SAN FRANCISCO, Calif. – Feb. 26, 2014 – Fluidigm Corporation (NASDAQ:FLDM) today announced that it will present at the Cowen and Company 34th Annual Health Care Conference in Boston, on Tuesday, March 4, 2014,
Fluidigm Reports Strong Revenue for Q4 and the Full Year 2013 - Full Year 2013 Revenue Up 36% SOUTH SAN FRANCISCO, Calif. – February 6, 2014 – Fluidigm Corporation (NASDAQ:FLDM) today announced its financial results for the fourth quarter and full year ended December 31, 2013.
Fluidigm to Announce Q4/Full Year 2013 Financial Results and Host Conference Call for Investors SOUTH SAN FRANCISCO, Calif., Jan. 31, 2014 — Fluidigm Corporation (NASDAQ:FLDM) will report its fourth quarter and 2013 full year financial results on February 6, 2014, after close of market.
Fluidigm Announces Pricing of $175 Million Convertible Senior Notes Offering SOUTH SAN FRANCISCO, CALIFORNIA, – January 30, 2014 – Fluidigm Corporation (NASDAQ: FLDM), a supplier of microfluidic systems for growth markets in the life science and agricultural biotechnology industries, today
